MSN Labs launches generic Cabozantinib for renal cancer treatment

MSN Labs launches generic Cabozantinib for renal cancer treatment

PTIUpdated: Thursday, September 23, 2021, 06:43 PM IST
article-image
MSN Labs' new Oncology Division will focus on presenting a comprehensive range of affordable high quality, bio-equivalent generic cancer drugs/ Representational image |

MSN Labs, a city-based pharma company on Thursday announced the launch of Cabolong, a branded generic of Cabozantinib for treatment of renal cell carcinoma.

The company's new Oncology Division will focus on presenting a comprehensive range of affordable high quality, bio-equivalent generic cancer drugs benefitting patients in the country, MSN labs said in a press release.

"Our endeavour at MSN Labs has always been to enable swift access to affordable life-saving medicines in critical therapeutic domains. Given the rising cancer incidence in our country and overwhelming treatment costs associated with it, launch of our dedicated oncology division demonstrates our unwavering commitment to patients' health and economic well-being." MSN Group said.

Cabolong is manufactured at MSN Labs' state-of-the-art facility approved by stringent global regulatory authorities like US FDA and EU GMP, it added.

RECENT STORIES

Amazon India, Flipkart Must Remove Products Infringing Reliance, Jio Trademarks: Delhi High Court

Amazon India, Flipkart Must Remove Products Infringing Reliance, Jio Trademarks: Delhi High Court

India, EU To Hold Next Round Of Free Trade Agreement Talks In September

India, EU To Hold Next Round Of Free Trade Agreement Talks In September

ICICI Prudential Life Q1 FY26 Profit Falls 21.8% QoQ, Premium Income Drops 48%

ICICI Prudential Life Q1 FY26 Profit Falls 21.8% QoQ, Premium Income Drops 48%

Gold Dips By ₹200 To ₹99,370 Per 10g, Silver Drops Sharply By ₹3,000 To Rs 1.12 Lakh/Kg

Gold Dips By ₹200 To ₹99,370 Per 10g, Silver Drops Sharply By ₹3,000 To Rs 1.12 Lakh/Kg

Exports Steady At USD 35.14 Bn In June, Trade Deficit Narrows To 4-Month Low Of USD 18.78 Bn

Exports Steady At USD 35.14 Bn In June, Trade Deficit Narrows To 4-Month Low Of USD 18.78 Bn